Results 111 to 120 of about 178,635,816 (158)

Comparison of thoracoabdominal versus abdominal-transhiatal surgical approaches in Siewert type II adenocarcinoma at the esophagogastric junction: Protocol for a prospective multicenter randomized controlled trial. [PDF]

Front Oncol, 2023
Yue C, Mo Z, Wu X, Wang Y, Yang Q, Wang W, Zhou H, Gao R, Ji P, Dong D, Zhang Y, Ji G, Li X.   +12 more
europepmc   +1 more source

Junction, Land of living waters in the delightful Hill Country of Texas.

, 1930
This pamphlet describes the city of Junction, its history, businesses, natural resources, and public works.Title from front and back panels. 'For any further information ... write to the Chamber of Commerce, Junction, Texas'--page 9. Front and back panel
Unknown
core  

Prognosis comparison and prognostic model construction in patients with Siewert type II adenocarcinoma of the esophagogastric junction after neoadjuvant therapy between proximal gastrectomy and total gastrectomy. [PDF]

J Thorac Dis
Shen G, Shi P, Yang P, Zhu B, Li Y, Chen S.   +5 more
europepmc   +1 more source

Esophagogastric Junction Adenocarcinoma: Multivariate Analyses Of Surgical Morbi-mortality And Adjuvant Therapy.

, 2015
In recent years the literature has recorded a progressive increase in the prevalence of adenocarcinoma of the esophagogastric junction. Several factors can interfere with the morbidity and mortality of surgical treatment.
Tercioti-Junior V., Lopes L.R., Carvalheira J.B., Andreollo N.A., Coelho-Neto J.S.   +4 more
core  

Integrated single-cell and bulk transcriptomic analyses reveal a stem-like epithelial subpopulation in adenocarcinoma of the esophagogastric junction and identify VASN as a novel regulator of tumor stemness. [PDF]

Front Immunol
Zheng H, Wang S, Liu H, Wang J, Hu B.
europepmc   +1 more source

Can Clinical Stage in the 8^th Edition of the Union for International Cancer Control TNM Classification Stratify the Prognosis of Patients Undergoing Curative Surgery for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction? [PDF]

In Vivo, 2023
Watanabe H, Hasegawa S, Kumazu Y, Hashimoto I, Komori K, Suematsu H, Kano K, Fujikawa H, Aoyama T, Yamada T, Yukawa N, Yoshikawa T, Rino Y, Saito A, Ogata T, Oshima T.   +15 more
europepmc   +1 more source

The value of 3D contrast-enhanced CT radiomics in predicting response to neoadjuvant chemotherapy for adenocarcinoma of the esophagogastric junction: a two-center study. [PDF]

BMC Cancer
Luo C, Li J, Mu W, Yuan M, Zhan P, Liu Y, Zhou Y, Li L, Ding C, Chen X, Gao J.   +10 more
europepmc   +1 more source

Influence of Primary Tumor Resection on Survival of Patients With Metastatic Siewert Type II Adenocarcinoma of the Esophagogastric Junction: A Population-Based, Propensity-Matched Analysis. [PDF]

Cancer Control, 2023
Chen J, Jia X, Chen H, Cai J, Chen L.
europepmc   +1 more source

The relationship between examined lymph nodes and oncological outcome of proximal gastrectomy for Siewert II/III adenocarcinoma of the esophagogastric junction. [PDF]

World J Surg Oncol
Wang H, Shao X, Lu Y, Hu H, Jiang Y, Li W, Xu Q, Tian Y.   +7 more
europepmc   +1 more source

Efficacy and survival analysis of neoadjuvant chemotherapy combined with immunotherapy in locally advanced resectable Siewert type II adenocarcinoma of the esophagogastric junction. [PDF]

Front Oncol
Gai C, Lv H, Feng C, Zhao X, Wang H, Sun B, Zhang F, Tian Z.   +7 more
europepmc   +1 more source